Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

SWHFX vs SCHLX overlap: 71% of top holdings shared

Bottom line

How much do SWHFX and SCHLX overlap?

71% of their top holdings overlap by weight. 16 securities appear in both funds' top 25, making up 60.1% of SWHFX's assets and 60.6% of SCHLX's. They are largely the same portfolio — owning both adds little diversification.

Updated Nov 22, 2026

Overlap at a glance

SWHFXSCHLX
Weight overlap (top 25)71%
Shared holdings16
Weight in shared holdings60.1%60.6%
Total positions8065
Expense ratio0.8%1.06%
Holdings as ofJul 31, 2026May 31, 2026

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)

Holdings SWHFX and SCHLX have in common

Holding% of SWHFX% of SCHLXOverlap
Eli Lilly & Co13.92%13.85%13.85%
Johnson & Johnson6.94%6.19%6.19%
AbbVie Inc5.81%4.90%4.90%
Merck & Co Inc4.98%4.85%4.85%
UnitedHealth Group Inc4.74%5.73%4.74%
Gilead Sciences Inc3.24%2.78%2.78%
Amgen Inc2.58%2.88%2.58%
Bristol-Myers Squibb Co2.44%1.50%1.50%
Medtronic PLC2.29%1.54%1.54%
Roche Holding AG2.29%1.24%1.24%
Thermo Fisher Scientific Inc2.16%3.46%2.16%
Stryker Corp2.11%2.61%2.11%
Vertex Pharmaceuticals Inc1.89%2.45%1.89%
Boston Scientific Corp1.60%2.10%1.60%
Abbott Laboratories1.60%2.39%1.60%
Danaher Corp1.47%2.13%1.47%

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in SWHFX

  1. Novartis AG — 2.92%
  2. Gsk Plc — 1.73%
  3. Cigna Group/The — 1.51%
  4. Elevance Health Inc — 1.45%
  5. Incyte Corp — 1.37%
  6. Ipsen SA — 1.34%
  7. Sanofi SA — 1.31%
  8. Becton Dickinson & Co — 1.24%
  9. Astellas Pharma Inc — 1.19%

Only in SCHLX

  1. AstraZeneca PLC — 3.80%
  2. Novartis AG — 2.90%
  3. Intuitive Surgical Inc — 2.69%
  4. McKesson Corp — 2.05%
  5. Novo Nordisk A/S — 1.73%
  6. Regeneron Pharmaceuticals Inc — 1.43%
  7. Cardinal Health Inc — 1.34%
  8. Cencora Inc — 1.26%
  9. Pfizer Inc — 1.17%

Asset mix

Asset typeSWHFXSCHLX
Stocks99.0%99.6%
Cash & short-term funds—0.5%

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)

Country mix

CountrySWHFXSCHLX
US78.6%85.7%
CH5.2%5.2%
IE4.5%1.5%
GB3.4%3.8%
FR2.6%1.0%
JP2.3%—
DK0.7%1.7%
NL0.7%1.0%

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)

Check another pair

FAQ

How much do SWHFX and SCHLX overlap?
About 71% by weight. 16 securities appear in both funds' top 25 holdings; they make up 60.1% of SWHFX's assets and 60.6% of SCHLX's. They are largely the same portfolio — owning both adds little diversification.
What stocks do SWHFX and SCHLX have in common?
The largest shared holdings are Eli Lilly & Co, Johnson & Johnson, AbbVie Inc, Merck & Co Inc, UnitedHealth Group Inc.
Should I own both SWHFX and SCHLX?
Owning both adds little diversification: most of their top holdings are the same, so most investors pick one — often the one with the lower expense ratio.
Which holds more stocks, SWHFX or SCHLX?
SWHFX is broader, with 80 positions versus 65 for SCHLX. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.